HK1216172A1 - 構象受限的完全合成的大環化合物 - Google Patents
構象受限的完全合成的大環化合物Info
- Publication number
- HK1216172A1 HK1216172A1 HK16103994.2A HK16103994A HK1216172A1 HK 1216172 A1 HK1216172 A1 HK 1216172A1 HK 16103994 A HK16103994 A HK 16103994A HK 1216172 A1 HK1216172 A1 HK 1216172A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fully synthetic
- macrocyclic compounds
- conformationally constrained
- synthetic macrocyclic
- conformationally
- Prior art date
Links
- 150000002678 macrocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D497/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2009/060168 WO2011015241A1 (en) | 2009-08-05 | 2009-08-05 | Conformationally constrained, fully synthetic macrocyclic compounds |
CN200980160767.8A CN102471349B (zh) | 2009-08-05 | 2009-08-05 | 构象受限的完全合成的大环化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1216172A1 true HK1216172A1 (zh) | 2016-10-21 |
Family
ID=42105962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16103994.2A HK1216172A1 (zh) | 2009-08-05 | 2012-10-30 | 構象受限的完全合成的大環化合物 |
Country Status (12)
Country | Link |
---|---|
US (2) | US9695191B2 (zh) |
EP (1) | EP2462147B8 (zh) |
JP (1) | JP5727479B2 (zh) |
CN (1) | CN102471349B (zh) |
AU (2) | AU2009350857A1 (zh) |
CA (2) | CA2769124A1 (zh) |
DK (1) | DK2462147T3 (zh) |
ES (1) | ES2530519T3 (zh) |
HK (1) | HK1216172A1 (zh) |
IL (2) | IL217003A0 (zh) |
SG (1) | SG177521A1 (zh) |
WO (2) | WO2011015241A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007079597A1 (en) | 2006-01-16 | 2007-07-19 | Polyphor Ltd. | Template - fixed peptidomimetics with antimicrobial activity |
EP2114986B1 (en) | 2007-01-29 | 2013-05-22 | Polyphor Ltd. | Template-fixed peptidomimetics |
JP5140686B2 (ja) | 2007-02-28 | 2013-02-06 | ポリファー リミテッド | テンプレート固定ペプチド模倣薬 |
CN102471349B (zh) * | 2009-08-05 | 2016-08-24 | 波利弗尔股份公司 | 构象受限的完全合成的大环化合物 |
DK2836485T3 (en) * | 2012-03-17 | 2018-04-23 | Polyphor Ag | CONFORMITY LIMITED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS |
WO2013142873A2 (en) | 2012-03-23 | 2013-09-26 | The Board Of Trustees Of The University Of Illinois | Complex and structurally diverse compounds |
TWI655213B (zh) * | 2012-07-13 | 2019-04-01 | 目立康股份有限公司 | 自我組織化肽衍生物的製造方法 |
AU2014315287A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
EP3215519A1 (en) | 2014-11-06 | 2017-09-13 | Novartis AG | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
JP2015155430A (ja) * | 2015-04-02 | 2015-08-27 | ポリフォー・アクチェンゲゼルシャフトPolyphor Ag | コンホメーションを固定された、合成マクロ環化合物 |
WO2017063757A1 (en) | 2015-10-12 | 2017-04-20 | Polyphor Ag | Conformationally constrained macrocyclic compounds |
WO2017063755A1 (en) | 2015-10-12 | 2017-04-20 | Polyphor Ag | Conformationally constrained macrocyclic compounds |
WO2017063754A1 (en) | 2015-10-12 | 2017-04-20 | Polyphor Ag | Conformationally constrained macrocyclic compounds as pin1 modulators |
WO2017063756A1 (en) * | 2015-10-12 | 2017-04-20 | Polyphor Ag | Conformationally constrained macrocyclic compounds as pin1 modulators |
EP3452492A1 (en) | 2016-05-05 | 2019-03-13 | Novartis AG | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
JP2017160247A (ja) * | 2017-05-10 | 2017-09-14 | ポリフォー・アクチェンゲゼルシャフトPolyphor Ag | コンホメーションを固定された、合成マクロ環化合物 |
US11267809B2 (en) | 2017-09-14 | 2022-03-08 | The Board Of Trustees Of The Leland Stanford Junior University | BAF complex modulating compounds and methods of using the same |
EP3820460A1 (en) | 2018-07-12 | 2021-05-19 | The Board of Trustees of the Leland Stanford Junior University | Methods for reversing hiv latency using baf complex modulating compounds |
CN113121567A (zh) * | 2021-04-22 | 2021-07-16 | 中国科学院大学 | 分子内正交结构的环状三吡咯化合物的合成方法 |
CN115057848B (zh) * | 2022-08-04 | 2023-08-18 | 江苏师范大学 | 一种轴手性异吡喃酮-吲哚衍生物及其合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5734012A (en) * | 1996-05-16 | 1998-03-31 | Ohmeda Pharmaceutical Products Division Inc. | Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
CA2405521C (en) * | 2000-04-05 | 2010-06-29 | Schering Corporation | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
JP4928261B2 (ja) * | 2003-06-18 | 2012-05-09 | トランザイム・ファーマ・インコーポレイテッド | モチリン受容体の大環状拮抗薬 |
US20070293548A1 (en) | 2006-03-31 | 2007-12-20 | Wang Eric Y | Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
CN102471349B (zh) * | 2009-08-05 | 2016-08-24 | 波利弗尔股份公司 | 构象受限的完全合成的大环化合物 |
-
2009
- 2009-08-05 CN CN200980160767.8A patent/CN102471349B/zh active Active
- 2009-08-05 JP JP2012523207A patent/JP5727479B2/ja active Active
- 2009-08-05 ES ES09781527T patent/ES2530519T3/es active Active
- 2009-08-05 EP EP09781527.8A patent/EP2462147B8/en active Active
- 2009-08-05 AU AU2009350857A patent/AU2009350857A1/en not_active Abandoned
- 2009-08-05 US US13/388,891 patent/US9695191B2/en active Active
- 2009-08-05 WO PCT/EP2009/060168 patent/WO2011015241A1/en active Application Filing
- 2009-08-05 CA CA2769124A patent/CA2769124A1/en not_active Abandoned
- 2009-08-05 SG SG2012000766A patent/SG177521A1/en unknown
- 2009-08-05 DK DK09781527.8T patent/DK2462147T3/en active
-
2010
- 2010-08-03 CA CA2780829A patent/CA2780829C/en active Active
- 2010-08-03 AU AU2010281287A patent/AU2010281287B2/en not_active Ceased
- 2010-08-03 US US13/508,531 patent/US9512139B2/en active Active
- 2010-08-03 WO PCT/CH2010/000191 patent/WO2011014973A2/en active Application Filing
-
2011
- 2011-12-15 IL IL217003A patent/IL217003A0/en unknown
-
2012
- 2012-04-30 IL IL219494A patent/IL219494B/en active IP Right Grant
- 2012-10-30 HK HK16103994.2A patent/HK1216172A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN102471349A (zh) | 2012-05-23 |
EP2462147A1 (en) | 2012-06-13 |
WO2011014973A3 (en) | 2011-04-21 |
WO2011015241A1 (en) | 2011-02-10 |
IL219494B (en) | 2018-04-30 |
AU2009350857A1 (en) | 2012-02-02 |
EP2462147B1 (en) | 2014-11-12 |
SG177521A1 (en) | 2012-02-28 |
CA2780829A1 (en) | 2011-02-10 |
AU2010281287B2 (en) | 2015-05-14 |
CN102471349B (zh) | 2016-08-24 |
EP2462147B8 (en) | 2015-03-18 |
JP5727479B2 (ja) | 2015-06-03 |
AU2010281287A1 (en) | 2012-08-02 |
CA2769124A1 (en) | 2011-02-10 |
DK2462147T3 (en) | 2015-02-23 |
IL219494A0 (en) | 2012-06-28 |
US20120202821A1 (en) | 2012-08-09 |
ES2530519T3 (es) | 2015-03-03 |
IL217003A0 (en) | 2012-02-29 |
US9695191B2 (en) | 2017-07-04 |
CA2780829C (en) | 2018-04-10 |
JP2013501009A (ja) | 2013-01-10 |
US20120270881A1 (en) | 2012-10-25 |
WO2011014973A2 (en) | 2011-02-10 |
US9512139B2 (en) | 2016-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1216172A1 (zh) | 構象受限的完全合成的大環化合物 | |
HRP20180615T1 (hr) | Tetraciklički spojevi | |
IL253516B (en) | tricyclic compounds | |
HK1179617A1 (zh) | -四氫- 氧氮雜䓬- -基胺或 -四氫- 氧氮雜䓬- -基胺化合物 | |
GB0906472D0 (en) | New compounds | |
GB0906470D0 (en) | New compounds | |
PL2488062T3 (pl) | Układ przesuwny | |
HK1206032A1 (zh) | 構象受限的全合成大環化合物 | |
AP2011006028A0 (en) | Bioprocessing. | |
GB0903493D0 (en) | New compounds | |
GB0900388D0 (en) | New compounds | |
AP2011005894A0 (en) | 5-alkynyl-pyridines. | |
AP2011005932A0 (en) | Pyrazinoisoquinoline Compounds. | |
HK1162032A1 (zh) | -三氟- -羥基丙基化合物 | |
GB201019221D0 (en) | No title, early entry | |
EP2431477A4 (en) | POLYTETIDE COMPOUND | |
AP2011005899A0 (en) | Plaswall. | |
GB0903525D0 (en) | Improved spindle lock | |
GB0909293D0 (en) | Aerobic step | |
GB201020866D0 (en) | . | |
GB0905912D0 (en) | D.C. Machine | |
GB0903183D0 (en) | . | |
GB0902615D0 (en) | . | |
GB0903558D0 (en) | . | |
GB0907991D0 (en) | . |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230803 |